Five-year follow-up of nivolumab in NSCLC
11 Apr 2017
Five-year follow-up of nivolumab in NSCLC
Olaparib and temozolomide for relapsed small cell lung cancer
Surgery over SBRT for early lung cancer
SBRT or surgery for early lung cancer?
Tobacco, lung cancer and non-smoking lung cancers
Screening for lung cancer - current status and recommendations
Advances in image contouring
Cimavax - a lung cancer vaccine
Standardised tobacco packaging in the UK
Personalised therapy for lung cancer
Current status in treating lung cancer
Combination immunotherapy for lung cancer